CVE:WMD WeedMD Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding WeedMD Inc. Please log in to your account or sign up in order to add this asset to your watchlist. C$0.28 -0.01 (-1.79%) (As of 07/15/2021) Add Compare Share Today's RangeC$0.28▼C$0.2950-Day RangeC$0.28▼C$0.2852-Week RangeC$0.23▼C$0.99Volume271,436 shsAverage Volume766,591 shsMarket CapitalizationC$67.82 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileAnalyst RatingsChartCompetitorsEarningsHeadlinesSocial Media WeedMD MarketRank™ ForecastAnalyst RatingN/AUpside/DownsideN/AShort InterestN/ADividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.0.81 out of 5 stars 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for WeedMD. Previous Next 0.0 Short Interest Short InterestThere is no current short interest data available for WMD. Previous Next 0.0 Dividend Strength Dividend YieldWeedMD does not currently pay a dividend.Dividend GrowthWeedMD does not have a long track record of dividend growth. Previous Next 0.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for WMD. Previous Next 3.4 News and Social Media Coverage News SentimentWeedMD has a news sentiment score of 1.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.84 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for WeedMD this week, compared to 0 articles on an average week.MarketBeat Follows1 people have added WeedMD to their MarketBeat watchlist in the last 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, WeedMD insiders have not sold or bought any company stock. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of WeedMD is -0.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of WeedMD is -0.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioWeedMD has a P/B Ratio of 0.81. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive WMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for WeedMD and its competitors with MarketBeat's FREE daily newsletter. Email Address About WeedMD (CVE:WMD) StockWeedMD Inc. produces, distributes, and sells medical-grade cannabis in Canada. It offers dried cannabis, cannabis plants and seeds, cannabis oil, edibles, extracts and topicals, and others, as well as cannabis flower products. The company sells its products directly to medical patients and strategic relationships across the seniors' market, as well as through supply agreements with Shoppers Drug Mart and six provincial distribution agencies under the Color Cannabis, Saturday, Starseed, and WeedMD brand names. WeedMD Inc. is headquartered in Aylmer, Canada.Read More WMD Stock News HeadlinesJuly 3, 2022 | americanbankingnews.comWeedMD (CVE:WMD) Shares Down 1.8% June 21, 2022 | finance.yahoo.comEntourage Health Provides Update on Proposed Amendments to its 8.5% Unsecured Convertible Debentures - Yahoo FinanceJune 20, 2022 | finance.yahoo.comEntourage Health Announces Debentureholders Overwhelmingly Approve Proposed Amendments to 8.5% Unsecured Convertible Debentures - Yahoo FinanceJune 15, 2022 | finance.yahoo.comEntourage Announces Results of 2022 Annual General Meeting of Shareholders - Yahoo FinanceJune 15, 2022 | streetinsider.comEntourage Announces Results of 2022 Annual General Meeting of Shareholders - StreetInsider.comMay 20, 2022 | finance.yahoo.comEntourage Health Reaffirms First Quarter 2022 Preliminary Record Revenues of $17.4 Million and Announces Financial Results Call to be held on May 31, 2022 - Yahoo FinanceMay 13, 2022 | finance.yahoo.comEntourage Health Enters into Voting Support Agreement and Announces Proposed Amendments to its 8.5% Unsecured Convertible Debentures - Yahoo FinanceMay 4, 2022 | finance.yahoo.comEntourage Health Partners with Pineapple Express to Provide Same-Day Medical Cannabis Delivery Service to its Starseed Medicinal Patients - Yahoo FinanceApril 29, 2022 | globenewswire.comEntourage Health and LiUNA Pension Fund Upsize Credit Facility with Additional $15 Million in Funding Availability - GlobeNewswireApril 22, 2022 | globenewswire.comEntourage Updates Timing of Fiscal Year 2021 Financial Results Call to May 3, 2022 - GlobeNewswireApril 22, 2022 | finance.yahoo.comEntourage Updates Timing of Fiscal Year 2021 Financial Results Call to May 3, 2022 - Yahoo FinanceMarch 25, 2022 | finance.yahoo.comEntourage Health Launches ‘Joints for Justice’ Retail Campaign to Raise Funds and Awareness in Support of Cannabis Amnesty - Yahoo FinanceMarch 24, 2022 | globenewswire.comEntourage Health Appoints Finance Executive Vaani Maharaj as New Chief Financial Officer and Updates Timing of Q4 and Full-Year 2021 Financials to April 26 - GlobeNewswireMarch 8, 2022 | globenewswire.comEntourage Health Debuts New 2022 Color Cannabis Branding - GlobeNewswireFebruary 12, 2022 | globenewswire.comEntourage Health Announces Preliminary Fiscal Year 2021 - GlobeNewswireFebruary 11, 2022 | finance.yahoo.comEntourage Health Announces Preliminary Fiscal Year 2021 Record Revenue of $54.8 Million with Q4 and Full-Year 2021 Financials to be filed by April 1, 2022 - Yahoo FinanceJanuary 28, 2022 | finance.yahoo.comBevCanna Closes Acquisition of Solventless Cannabis Extraction and Delivery Technology Provider Embark Health Inc. - Yahoo FinanceJanuary 24, 2022 | businesswire.comFlora Growth Appoints Industry-Leading Cultivator Derek Pedro as Genetics and Cultivation Advisor - Business WireDecember 27, 2021 | benzinga.comEntourage Health Upsizes Credit Facility With LiUNA Pension Fund For Extra $20M - Benzinga - BenzingaDecember 24, 2021 | globenewswire.comEntourage Health and LiUNA Pension Fund Upsize Credit Facility with Additional $20 Million in Non-Dilutive Financing - GlobeNewswireNovember 29, 2021 | globenewswire.comEntourage Health Launches Cannabis-Infused Soft Chews for - GlobeNewswireNovember 16, 2021 | benzinga.comEntourage Health Posts $14.9 Million Record Revenue In Q3 Following Rebrand From WeedMD - Benzinga - BenzingaNovember 1, 2021 | globenewswire.comEntourage Health Closes Acquisition of Craft Cultivator CannTx Life Sciences Inc. - GlobeNewswireOctober 19, 2021 | finance.yahoo.comEntourage Health Announces Preliminary Q3 Record Revenue of $14.7 Million and Confirms Financial Results Call to be Held on November 16, 2021 at 10 am ET - Yahoo FinanceOctober 15, 2021 | globenewswire.comEntourage Health Announces Filing of Amended Financial - GlobeNewswireSee More Headlines Industry, Sector and Symbol Stock ExchangeCVE Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolCVE:WMD CUSIPN/A CIKN/A Webwww.weedmd.com Phone+1-416-5153923FaxN/AEmployees212Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio95.63 Current Ratio3.46 Quick Ratio1.46 Sales & Book Value Annual SalesC$27.53 million Price / Sales2.46 Cash FlowC$0.08 per share Price / Cash Flow3.27 Book ValueC$0.34 per share Price / Book0.81Miscellaneous Outstanding Shares246,624,000Free FloatN/AMarket CapC$67.82 million OptionableNot Optionable BetaN/A WeedMD Frequently Asked Questions How has WeedMD's stock price performed in 2022? WeedMD's stock was trading at C$0.28 on January 1st, 2022. Since then, WMD stock has increased by 0.0% and is now trading at C$0.28. View the best growth stocks for 2022 here. Who are WeedMD's key executives? WeedMD's management team includes the following people: Mr. George Scorsis, Interim CEO & Exec. Chair of the Board (Age 45, Pay $200.68k)Mr. Angelo Tsebelis, AdvisorMr. Jason Alexander, Chief Strategy Officer & DirectorMs. Beth Carreon, Chief Financial OfficerMr. Jeff Keyes, VP of OperationsDr. Alexandre Sibilev, Vice-Pres of Quality Assurance & Global Regulatory ComplianceMs. Marianella delaBarrera, VP of Communications & Corp. AffairsMr. Joseph Mele, Sr. VP of Commercial, Sales & MarketingMs. Deborah Sikkema, Chief People OfficerMr. Michael P. Kraft, Strategic Advisor to the board (Age 58) Who are some of WeedMD's key competitors? Some companies that are related to WeedMD include Supreme Cannabis (FIRE), ESSA Pharma (EPI), ICC Labs (ICC), Leaf Mobile (LEAF), Medexus Pharmaceuticals (MDP), HEXO (HEXO), BioSyent (RX), Green Organic Dutchman (TGOD), Delta 9 Cannabis (NINE), Science in Sport (SIS), Cipher Pharmaceuticals (CPH), Venture Life Group (VLG), Viridium Pacific Group (VIR), Zomedica Pharmaceuticals Corp. (ZOM.V) (ZOM) and InMed Pharmaceuticals (IN). View all of WMD's competitors. What other stocks do shareholders of WeedMD own? Based on aggregate information from My MarketBeat watchlists, some companies that other WeedMD investors own include (CGC), Aurora Cannabis (ACB), Canopy Growth (WEED), Aphria (APHA), Cara Therapeutics (CARA), Cronos Group (CRON), Tencent (TCEHY), Aduro Biotech (ADRO), Aurora Cannabis (ACB) and Auxly Cannabis Group (CBWTF). What is WeedMD's stock symbol? WeedMD trades on the Canadian Venture Exchange (CVE) under the ticker symbol "WMD." How do I buy shares of WeedMD? Shares of WMD and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What is WeedMD's stock price today? One share of WMD stock can currently be purchased for approximately C$0.28. How much money does WeedMD make? WeedMD (CVE:WMD) has a market capitalization of C$67.82 million and generates C$27.53 million in revenue each year. How many employees does WeedMD have? WeedMD employs 212 workers across the globe. How can I contact WeedMD? WeedMD's mailing address is 320 Bay St Suite 1600, TORONTO, ON M5H 4A6, Canada. The official website for WeedMD is www.weedmd.com. The company can be reached via phone at +1-416-5153923. This page (CVE:WMD) was last updated on 7/6/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here
